This continues a steady rise in pay for the specialty—the same report recorded cardiology’s average salary as $430,000 in 2019, $423,000 in 2018 and $410,000 in 2017.

As COVID-19 patients begin to bounce back, they are sure to have plenty of important questions about the recovery process. 

Omecamtiv mecarbil, a cardiac myosin activator being manufactured by Amgen and Cytokinetics to treat heart failure with reduced ejection fraction, has been granted a Fast Track designation by the FDA.

Drinking just one sugary drink per day can increase a woman’s risk of cardiovascular disease (CVD) by 19%, according to new findings published in the Journal of the American Heart Association.

Heart transplant (HT) recipients have an increased risk of experiencing severe complications if infected with COVID-19, according to new findings published in JAMA Cardiology.

Royal Philips announced Wednesday, May 13, that its ultrasound imaging solutions have been cleared by the FDA for the management of cardiac and lung complications associated with COVID-19.

Cardiovascular disease (CVD) age-adjusted mortality rates (AAMRs) were higher in rural areas than larger metropolitan areas from 1999 to 2017, according to new research published in JAMA.

As use of cannabis products increases and evidence of possible cardiovascular harm mounts, it’s time for cardiologists to start having conversations with their patients.